CCB International

CCB International (Holdings) Limited, established in 1973, is an investment services firm based in Hong Kong and owned by China Construction Bank Corporation. The company operates across a comprehensive value chain that encompasses three primary segments: Pre-IPO, IPO, and Post-IPO services. CCB International offers a wide array of services, including underwriting, financial advisory, corporate mergers and acquisitions, restructuring, and refinancing for listed companies. Additionally, the firm engages in direct investment and asset management, alongside providing securities brokerage, market research, and investment consultancy. Through its subsidiaries, such as CCB International Capital and CCB International Asset Management, the firm delivers diverse investment solutions and services to meet the needs of its clientele.

Alvin Li MD

Managing Director

Michael Steinberg

Managing Director and CEO

Kaipeng Xia

Managing Director, Direct Investment

68 past transactions

Xinqiang Technology

Series A in 2025
Xinqiang Technology is a digital full-stack solution provider specializing in integrated solutions that combine hardware, software, cloud services, and artificial intelligence (AI) tailored for traditional industries.

Syngenta

Debt Financing in 2024
Syngenta is a global agriculture company dedicated to bringing plant potential to life. With over 28,000 employees in nearly 90 countries, Syngenta develops innovative crop solutions, including seeds, pesticides, and biotechnology, to help farmers increase yields and improve sustainability.

Galaxy Bot

Venture Round in 2024
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.

Sinogene

Series C in 2024
Sinogene is a biotechnology company that specializes in pet cloning using somatic cell nuclear transfer technology. The company's team comprises scientists, doctors, and veterinary specialists who aim to advance animal genetic research through their services. Sinogene focuses on cloning and breeding various types of dogs, including working, pet, and purebred noble breeds, as well as preserving somatic cells' genes for future use in pet cloning and gene editing services.

Hangzhou Times Electric Technology

Series A in 2023
Times Electric is a developer of new energy vehicles and core components.

Thor Innovation

Series A in 2023
Thor Innovation is a high-tech enterprise focused on haptic technology, which provides electronic simulations of tactile sensations. The company specializes in developing and manufacturing haptic solutions for various industries, including consumer electronics, automotive, and healthcare. Thor Innovation's wide-band haptic technology and integrated solutions are designed to deliver immersive experiences that enhance extended reality and digital interactions through realistic physical feedback. This approach allows consumers to engage more fully with their devices, resulting in a more authentic and engaging user experience.

Chilye

Venture Round in 2022
Chilye is a company specializing in high-power electronic components and high-voltage connectors, primarily for the new energy vehicle sector. It offers a range of products including power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. Chilye is dedicated to advancing the development of high-voltage electrical units aimed at supporting alternative energy vehicles. Through its focus on technical research and development, the company provides comprehensive solutions for complete vehicle systems, catering to the growing demand for innovative technologies in the electric vehicle market.

GalaxySpace

Series D in 2022
Founded in 2016, GalaxySpace specializes in developing and manufacturing low Earth orbit (LEO) broadband satellite constellations for global internet connectivity. Their satellite applications include monitoring services for airports, parking lots, oil reserves, and land use assessment.

Origin Quantum

Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China. It provides a quantum computing cloud service platform and engages in the development of quantum hardware, control systems, software, and quantum AI to enable practical use of quantum computers beyond laboratories. Established in 2017, the company focuses on accelerating the engineering, deployment, and industrialisation of quantum computing in China by offering a superconducting quantum computing cloud and related ecosystem.

TargetRx

Series B in 2022
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.

Mirxes

Series C in 2022
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.

Tianbing Technology

Series B in 2022
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Keydom

Post in 2022
Keydom is the provider of smart card industry application solution services.

Moore Threads

Series A in 2021
Founded in 2020, Moore Threads specializes in developing Graphics Processing Unit technology for corporate clients across sectors such as gaming, creative industries, and artificial intelligence. Its GPU solutions cater to data centers, edge computing servers, professional workstations, and high-performance PCs.

Wego

Series A in 2021
Wego is a manufacturer of producing safe and affordable medical equipment.

Hozon

Series D in 2021
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company produces models such as the Nezha U, Nezha N01, and Eureka 02, focusing on integrating innovative technology through research and development. Hozon emphasizes intelligent manufacturing and multi-channel sales services, aiming to deliver high-quality, cost-effective intelligent electric vehicles. By prioritizing advancements in electricity, intelligence, and connectivity, Hozon seeks to enhance the user experience, providing a simple, intuitive, and comfortable mode of transportation. The company also maintains research and development centers in both China and the United States.

SJ Semi

Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

IASO Biotherapeutics

Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company founded in 2017 and based in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies for cancer, particularly through engineered autologous and allogenic T cell therapies. These therapies are designed to enhance the immune system's ability to recognize and eliminate cancer cells, positioning IASO Biotherapeutics as a key player in the oncology field.

OrbusNeich Medical

Series B in 2021
OrbusNeich Medical is a global leader in vascular intervention solutions. It offers an extensive range of products that set industry standards.

Kuaikan Manhua

Series F in 2021
Kuaikan Manhua is an online and mobile platform for original online comic artwork targeting young readers. Founded in 2014, Kuaikan Manhua is a comic-reading platform and community of interest that is popular among users. As of January 2019, the total number of users of the comics app is over 170 million, and the monthly users are over 40 million, and the market share in the comics market is more than half*. Kuaikan World’s vision is to build an ideal ecosystem of cultural-entertainment in the future, as well as bring happiness to the world. Kuaikan aims to help comic creators to create more widely-popular comics with positive, energetic and warm contents to millions of users.

Beijing Health Guard Biotechnology

Private Equity Round in 2021
Beijing Health Guard Biotechnology is a research and development firm based in Beijing, China, founded in 2008. The company focuses on the development of recombinant protein drugs and vaccines for the biotech industry. Its primary emphasis is on the research and industrialization of recombinant protein vaccines, particularly human papillomavirus (HPV) vaccines. Beijing Health Guard Biotechnology is advancing several innovative candidate vaccines targeting various infectious diseases, with its core pipeline featuring both trivalent and nonavalent HPV vaccines. The company employs a structure-guided design approach in its biopharmaceutical research and development efforts.

SVOLT

Series B in 2021
SVOLT specializes in the manufacturing of electric vehicle batteries. Their product portfolio includes automotive power batteries and energy storage systems, catering to passenger cars, commercial vehicles, and energy storage markets.

Beijing Gene+ Technology

Series C in 2021
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of services, including clinical testing, medical device manufacturing, and scientific cooperation related to precision medicine. Operating in approximately 100 hospitals, Beijing Gene+ Technology has supported thousands of cancer patients across the country, contributing to advancements in personalized healthcare and tumor treatment strategies.

Geneplus-Beijing

Series C in 2021
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.

Shanghai Cell Therapy Group

Series D in 2021
Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.

Didi Woya

Series A in 2021
Didi Woya is a pioneering startup focused on creating autonomous vehicles for rideshares. Their goal is to revolutionize transportation services by providing efficient, affordable, and comfortable rides with rapid response times and budget-friendly fares. Utilizing cutting-edge technologies such as machine learning, the Internet of Things, and comprehensive 360-degree monitoring, DiDi Woya is dedicated to developing and commercializing innovative solutions in the field.

Youyun

Debt Financing in 2020
Youyun is the designer of a full-stack operation and maintenance service platform aimed at increasing company efficiency. They specialize in creating a variety of cloud-based business software solutions that increase the effectiveness of enterprise management and maintenance while enabling quick and efficient digital transportation for a range of sectors.

Biostar Technologies

Series E in 2020
Beijing Biostar Technologies, Ltd., established in 2002, is a biopharmaceutical company based in Beijing, China. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company was founded by a team of Chinese scientists led by Dr. Tang Li and Dr. Qiu Rongguo, who previously worked in the United States. Biostar Technologies pioneered the creation of new anti-cancer drugs based on epothilone in China and its technology is recognized as being at the international advanced level.

UtmoLight

Seed Round in 2020
UtmoLight is engaged in the research, development, and manufacture of perovskite-based photovoltaic and optoelectronic products. The company specializes in a range of technologies, including perovskite solar cells, light-emitting quantum dots, and the industrialization of perovskite technology. UtmoLight focuses on synthesizing high-quality perovskite quantum dots that cover the full visible spectrum, as well as developing enhanced filter films utilizing these quantum dots. By delivering innovative solutions in the photovoltaic sector, the company aims to provide clients with advanced materials derived from calcium titanium ore for various applications in the photoelectric field.

Hinova Pharma

Series C in 2020
Hinova Pharmaceuticals Inc. is a drug discovery and development company based in Chengdu, China, with additional branches in Hong Kong, Texas, and Australia. Established in 2013, the company specializes in the research and manufacturing of innovative medicines to address unmet medical needs, particularly in oncology and metabolic diseases. Utilizing advanced technology platforms such as deuterium and PROTAC, Hinova develops both Best-in-class and First-in-class drugs. Its product pipeline includes the HC-1119 androgen receptor antagonist and HC-1102 androgen receptor inhibitors, which target advanced prostate cancer and breast cancer. The company's commitment lies in providing safe, effective, and affordable treatments while retaining global rights and interests in its drug portfolio.

Sinovent

Series C in 2020
Sinovent, established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and offices in Beijing, China, and Boston, U.S.A. It specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in various stages of development, leveraging its expertise in science, management, and finance to deliver innovative solutions to patients worldwide.

Thousand Oaks Biopharmaceuticals

Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.

TargetRx

Series A in 2020
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.

Intellifusion

Series C in 2020
Founded in 2014, Intellifusion specializes in AI-driven digital twin city solutions for public safety, social governance, new business, and AIoT sectors. Its products include algorithm software, chips, modules, cards, IP licensing, and customization services.

Immunocore

Series B in 2020
Immunocore is a biotechnology company focused on developing novel T cell receptor-based therapies to treat diseases with high unmet needs, such as cancer and viral infections. Its proprietary platform enables the creation of bispecific immunotherapies, with IMCgp100 being its lead clinical candidate for metastatic melanoma.

Suzhou Kintor Pharmaceuticals

Series D in 2019
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Chengjia Apartment

Series A in 2019
Chengjia Apartment is a rental start-up based in Shanghai, China, that offers a variety of accommodation options including apartments, hotels, and homestays. Founded in 2015, the company provides flexible rental terms ranging from weekly to long-term stays, catering to diverse customer needs. Chengjia Apartment focuses on creating a high-quality living environment, combining the comforts of home with hotel-style services to ensure a warm and comfortable experience for its guests. The business has expanded significantly, managing nearly 100 properties across major cities in China and offering over 10,000 houses and related services. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital, reflecting a strong partnership in the hospitality sector.

Boston Micro Fabrication

Series A in 2019
Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.

Vapo Health

Series A in 2019
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.

Inspur Cloud

Series B in 2019
Inspur Cloud, established in 2010 with headquarters in Jinan, China, specializes in providing global datacenter and cloud computing solutions. It offers a range of hardware including servers and storage systems, along with software solutions such as artificial intelligence and high-performance computing platforms. Inspur Cloud caters to diverse clients, including governments, enterprises, and industries, aiming to enhance their transparency and efficiency through secure digital transformation.

Emirates National Oil Company

Debt Financing in 2019
Emirates National Oil Company (ENOC), established in 1993 and wholly owned by the Dubai Government, plays a pivotal role in the economic diversification and sustainable development of the United Arab Emirates. Based in Dubai, ENOC focuses on both upstream and downstream activities in the oil and gas sector. Over the years, the company has diversified its operations, expanding into various high-growth sectors to generate long-term value for its stakeholders while providing oil and gas services to clients worldwide.

Momenta

Series C in 2018
Momenta is an autonomous driving startup based in Beijing that specializes in developing advanced software solutions for full autonomy in vehicles. The company leverages deep learning technologies for perception, high-definition semantic mapping, and data-driven path planning, providing multi-level autonomous driving solutions alongside big data products and services. Momenta's team includes leading experts in computer vision and deep learning, contributing to the company's innovative approach to autonomous driving. Their technology is designed to enhance driving efficiency and safety, aiming to improve the overall experience for users through artificial intelligence.

Pengyang Medical

Series A in 2018
Pengyang Medical specializes in the development of medical monitoring hardware and information products, with a particular focus on electrocardiogram (ECG) artificial intelligence technology. The company aims to enhance cardiovascular diagnostic services by integrating advanced technologies with medical resources. Through research and development, Pengyang Medical creates innovative ECG solutions that provide detailed insights into patients' cardiovascular health, helping practitioners to improve diagnostic accuracy and reduce the likelihood of misdiagnoses.

Suning.com

Series A in 2018
Suning.com is a prominent Chinese online shopping platform that offers a wide range of products, including clothing, snacks, electronics, and appliances. The company emphasizes a comprehensive retail experience by integrating smart retail solutions with full category operations and omni-channel services, enabling customers to shop seamlessly through physical stores, mobile devices, PCs, and TVs. Additionally, Suning.com leverages logistics and global expansion strategies to enhance its service offerings. Founded in 1990, Suning Holdings Group, which includes Suning.com, has established itself as a leading commercial enterprise in China, recognized for its significant annual revenue and diverse business interests across various sectors, including logistics, financial services, and media. Suning's commitment to improving the quality of life through technological advancements and innovative retail solutions underscores its influence in the retail landscape.

Ascentage Pharma

Series C in 2018
Ascentage Pharma is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancers, hepatitis B virus (HBV), and age-related diseases. Its pipeline comprises seven drug candidates targeting protein-protein interactions and tyrosine kinases.

Blocksteam

Series A in 2018
Blocksteam is a Gaming company.

LLVision

Series B in 2018
LLVISION was founded in 2014 by an elite team from Google, Lenovo, Microsoft, Intel, China Aeronautics, Nokia, Broadcom, etc.Their mission is to help the industry leaders intellectualize business processes through the first perspective innovation linked with multi-dimension connections, cognition and synergy and upgraded human-machine collaboration.

8Trip

Series C in 2018
8Trip, a China-based online travel service which connects suppliers with sellers. Currently, 8Trip covers the markets of Wuxi, Nanjing, and Anhui in China, and is planning to enter the Shanghai market next year. The company has partnerships with about 1,000 travel agencies and more than 4,000 service outlets. 8Trip was founded in December 2011 under the company name Octopus Online Tourism Development, with headquarters in Suzhou.

Oxford Nanopore Technologies

Venture Round in 2018
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Innocare

Venture Round in 2018
InnoCare is a biopharmaceutical company based in China, focused on the discovery and development of innovative treatments for cancer and autoimmune diseases. The company boasts a highly skilled scientific team with extensive drug innovation experience in both the United States and China, supported by a distinguished Scientific Advisory Board composed of experts from top universities, hospitals, and the pharmaceutical industry. InnoCare's product pipeline includes a range of therapies, such as orelabrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune diseases. The company aims to make significant advancements in the treatment of conditions related to abnormal B-cell and T-cell functions, thereby contributing to the global fight against these diseases.

Chezhency.com

Series B in 2018
Chezhency.com is a B2B auto trading platform based in Shenzhen, China, founded in 2015. The company specializes in integrating various services related to the automotive industry, including automotive logistics, supply chain finance, consumer credit, and automobile insurance. By unifying these services, Chezhency.com aims to streamline the trading process for businesses involved in the automotive sector, enhancing efficiency and facilitating smoother transactions.

Suzhou Kintor Pharmaceuticals

Series C in 2018
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

ByteDance

Series D in 2017
ByteDance develops global digital content platforms like TikTok and Douyin, fostering user connection and creativity through short videos. It also offers enterprise collaboration tools and AI services, driven by advanced recommendation engines.

CooTek

Series D in 2017
Founded in 2008, CooTek is a global mobile internet company specializing in innovative mobile apps and artificial intelligence technology. Its flagship product, TouchPal Keyboard, offers superior input experiences for Android and iPhone users. CooTek's content-rich apps span fitness, lifestyle, healthcare, news, short videos, and entertainment verticals, serving over 213 million monthly active users worldwide. Headquartered in Shanghai with offices across Asia and Silicon Valley, CooTek holds over 170 patents globally.

Sooner

Angel Round in 2017
Sooner develops video technology products and services.

MEGVII

Series C in 2016
Megvii, founded in 2011, is an artificial intelligence company that specializes in intelligent solutions and data services for enterprises and developers. The company is focused on its mission to create machines capable of seeing and thinking, leveraging its deep learning system, Brain++. Megvii aims to build a comprehensive AI engine that serves as the foundational technology for various applications. It connects standardized hardware, such as sensors and personal devices, with artificial intelligence and the Internet of Things (AIoT), commercializing three main application areas: Consumer IoT, City IoT, and Supply Chain IoT. By integrating hardware and software solutions, Megvii enables clients to efficiently establish AI infrastructure tailored to their needs, positioning itself as an expert in AIoT solutions.

Shouqi Car Rental

Venture Round in 2016
Shouqi Car Rental is a car rental service and a subsidiary of Shouqi Group, a transportation company headquartered in China. It provides both business-to-business and business-to-consumer car rental solutions for institutional and individual customers. The company specializes in offering short-term and long-term rental options, allowing users to access vehicles on-demand by the hour or day. Shouqi Car Rental operates in various locations, including cities and airports within China and internationally, facilitating convenient transportation for its clientele.

Firstp2p

Series C in 2016
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to access traditional bank financing. Through its platform, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing solutions, aimed at supporting the needs of these businesses. This model allows Firstp2p to facilitate alternative financing options while providing investors with opportunities to engage in direct lending.

Firefly Games

Venture Round in 2016
Firefly Games is a global developer and publisher of mobile games for iOS and Android, with offices in Los Angeles and Shanghai. The company focuses on mid-core and hardcore titles and emphasizes community-driven, story-based experiences that receive regular updates. It operates across international markets and supports formats such as virtual reality and esports. The team has origins in notable studios and brings experience from a range of mobile, PC, and browser titles, enabling ongoing, connective gaming experiences for players worldwide.

Weidong Cloud Education

Venture Round in 2016
Weidong Cloud Education Group is focused on bridging the educational divide between various regions by enhancing education through technology. The company develops an internet-based educational ecosystem that offers a wide range of courses, including basic, vocational, and international education in sectors such as finance, management, medicine, and technology. Utilizing integrated "Cloud + Client" solutions, the company collaborates with leading global enterprises in software and hardware to create a comprehensive public service platform for educational resources. This initiative includes the establishment of a cloud data center and the Weidong International Education Cloud Industrial Park in Qingdao's Blue Silicon Valley, aimed at delivering high-quality educational services worldwide.

Ant Group

Series B in 2016
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.

Wellong Etown

Venture Round in 2016
Wellong Etown allows the clients to travel by car and ship all over the world, with high income and low cost for finding online smart load. Huilong installs a satellite positioning terminal for you with low fees and good service. The company finds empty trucks for your goods to be transported. It also transports online dispatching calls with high efficiency and punctuality.

Phylion Battery

Series A in 2015
Founded in 2003, Phylion Battery specializes in manufacturing power lithium-ion batteries for electric vehicles (EV/HEV), light EVs like e-bikes and scooters, and energy storage applications. With an annual production capacity of 5GWh, the company has served over 8 million end-users worldwide through its innovative and sustainable battery solutions.

XYWY.com

Series B in 2015
XYWY.com is an online platform dedicated to providing a range of medical services to users. The platform enables individuals to search for medical professionals and access free consultations, facilitating the acquisition of medical information and diagnoses. In addition to these services, XYWY.com offers appointment registration and guidance for drug searches and shopping, allowing clients to manage their healthcare needs efficiently through a single interface. By streamlining access to medical resources, XYWY.com aims to enhance the healthcare experience for patients.

Firstp2p

Series A in 2014
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to access traditional bank financing. Through its platform, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing solutions, aimed at supporting the needs of these businesses. This model allows Firstp2p to facilitate alternative financing options while providing investors with opportunities to engage in direct lending.

Taikang Bybo Dental

Series B in 2012
Taikang Bybo Medical Group is a prominent national dental medical group in China, specializing in comprehensive oral healthcare services for middle and upper-income demographics. The company is committed to delivering high-quality dental treatments and preventive care tailored to all age groups, aiming to enhance long-term oral health and overall well-being. By pursuing an exceptional customer experience and exploring innovative models in the dental sector, Taikang Bybo seeks to establish itself as the leading high-end dental chain brand in the country.

Galloping Horse

Private Equity Round in 2011
Beijing Galloping Horse Film & TV Production Co., Ltd. is a prominent company engaged in the production and distribution of films, television series, and advertising solutions. Founded in 2003 and based in Beijing, China, the company has established a strategic partnership with Digital Domain Media Group. Galloping Horse specializes in creating content that caters to the elite class in China, providing them with entertainment options for social gatherings. Through its comprehensive advertising and production services, the company plays a significant role in the Chinese entertainment industry.

Green Leader

Convertible Note in 2010
Green Leader Holdings Group Ltd is a mineral exploration and development company primarily focused on investments in the mining sector, with a significant presence in Mongolia. The company operates through four main segments: Mining Operations, which involves geological surveys, exploration, and the development and sale of coking coal; Systems Integration Services and Software Solutions, offering IT products, systems integration, technology services, and software development; Cassava Starch Operations, which focuses on the cultivation and processing of cassava starch for commercial sale; and Coal Operations, which specializes in coal trading. Through these diverse segments, Green Leader aims to leverage opportunities in both the mining and technology industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.